Kevin M. Farr's Insider Trades & SAST Disclosures
Kevin M. Farr's most recent trade in Polaris Inc was a trade of 4,320 Common Stock done at an average price of $34.7 . Disclosure was reported to the exchange on May 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kevin M. Farr.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 34.72 per share. | 01 May 2025 | 4,320 | 22,075 (0%) | 0% | 34.7 | 149,990 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 83.28 per share. | 25 Apr 2024 | 1,801 | 17,024 (0%) | 0% | 83.3 | 149,987 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 102.72 per share. | 02 Oct 2023 | 359 | 15,008 (0%) | 0% | 102.7 | 36,875 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Sale of securities on an exchange or to another person at price $ 133.28 per share. | 03 Aug 2023 | 3,225 | 14,644 (0%) | 0% | 133.3 | 429,828 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Sale of securities on an exchange or to another person at price $ 134.33 per share. | 27 Jul 2023 | 1,615 | 17,869 (0%) | 0% | 134.3 | 216,943 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 122.51 per share. | 03 Jul 2023 | 301 | 19,400 (0%) | 0% | 122.5 | 36,876 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 108.71 per share. | 27 Apr 2023 | 1,380 | 19,014 (0%) | 0% | 108.7 | 150,020 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 111.25 per share. | 03 Apr 2023 | 309 | 17,634 (0%) | 0% | 111.2 | 34,375 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 100.51 per share. | 03 Jan 2023 | 342 | 17,240 (0%) | 0% | 100.5 | 34,375 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 98.22 per share. | 03 Oct 2022 | 175 | 16,759 (0%) | 0% | 98.2 | 17,188 | Common Stock |
| Niagen Bioscience Inc. | Kevin M. Farr | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2022 | 89,189 | 89,189 | - | - | Restricted Stock Unit | |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 101.11 per share. | 01 Jul 2022 | 170 | 16,506 (0%) | 0% | 101.1 | 17,188 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 97.63 per share. | 28 Apr 2022 | 1,486 | 16,254 (0%) | 0% | 97.6 | 145,078 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 106.96 per share. | 01 Apr 2022 | 149 | 14,768 (0%) | 0% | 107.0 | 15,937 | Common Stock |
| Niagen Bioscience Inc. | Kevin M. Farr | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 122,374 | 122,374 | - | - | Employee Stock Options (right to buy) | |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 110.67 per share. | 03 Jan 2022 | 144 | 14,549 (0%) | 0% | 110.7 | 15,937 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Sale of securities on an exchange or to another person at price $ 115.28 per share. | 28 Oct 2021 | 10,168 | 14,340 (0%) | 0% | 115.3 | 1,172,176 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 121.53 per share. | 01 Oct 2021 | 273 | 24,509 (0%) | 0% | 121.5 | 33,179 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 134.91 per share. | 01 Jul 2021 | 227 | 24,185 (0%) | 0% | 134.9 | 30,625 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 137.52 per share. | 29 Apr 2021 | 1,018 | 23,858 (0%) | 0% | 137.5 | 139,995 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 135.37 per share. | 01 Apr 2021 | 217 | 22,840 (0%) | 0% | 135.4 | 29,376 | Common Stock |
| Niagen Bioscience Inc. | Kevin M. Farr | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 28,461 | 28,461 | - | - | Employee Stock Options (right to buy) | |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 96.00 per share. | 04 Jan 2021 | 306 | 22,535 (0%) | 0% | 96.0 | 29,375 | Common Stock |
| Niagen Bioscience Inc. | Kevin M. Farr | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 4.43 per share. | 06 Nov 2020 | 5,000 | 41,625 (0%) | 0% | 4.4 | 22,150 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 94.76 per share. | 01 Oct 2020 | 310 | 22,107 (0%) | 0% | 94.8 | 29,375 | Common Stock |
| Polaris Inc | Kevin M. Farr | Director | Grant, award, or other acquisition of securities at price $ 91.03 per share. | 01 Jul 2020 | 276 | 21,673 (0%) | 0% | 91.0 | 25,125 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges